PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.68%
Revenue growth under 50% of META's 12.29%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
5.39%
Gross profit growth under 50% of META's 12.33%. Michael Burry would be concerned about a severe competitive disadvantage.
-9.55%
Negative EBIT growth while META is at 10.27%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-9.55%
Negative operating income growth while META is at 16.44%. Joel Greenblatt would press for urgent turnaround measures.
-7.69%
Negative net income growth while META stands at 10.17%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-8.02%
Negative EPS growth while META is at 10.47%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-7.80%
Negative diluted EPS growth while META is at 11.04%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.36%
Slight or no buybacks while META is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.19%
Slight or no buyback while META is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
0.85%
OCF growth under 50% of META's 6.39%. Michael Burry might suspect questionable revenue recognition or rising costs.
5.16%
Positive FCF growth while META is negative. John Neff would see a strong competitive edge in net cash generation.
3381.31%
10Y revenue/share CAGR above 1.5x META's 1223.16%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
3381.31%
5Y revenue/share CAGR above 1.5x META's 190.49%. David Dodd would look for consistent product or market expansions fueling outperformance.
386.56%
3Y revenue/share CAGR above 1.5x META's 77.04%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
563.93%
3Y OCF/share CAGR above 1.5x META's 125.05%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
3765.32%
Net income/share CAGR 1.25-1.5x META's 2770.56%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
3765.32%
5Y net income/share CAGR above 1.5x META's 304.58%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
929.57%
3Y net income/share CAGR above 1.5x META's 194.47%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1600.93%
3Y equity/share CAGR above 1.5x META's 66.56%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
11.62%
AR growth well above META's 14.10%. Michael Burry fears inflated revenue or higher default risk in the near future.
52.30%
Inventory growth of 52.30% while META is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
7.04%
Asset growth 1.25-1.5x META's 5.19%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
6.59%
1.25-1.5x META's 5.80%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
30.30%
R&D growth drastically higher vs. META's 6.52%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
19.69%
SG&A growth well above META's 12.01%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.